Evidence map›Paper›PMID 31293971›Full record

ArticleFrontiers in oncology2019

Feasibility of Dose Escalation in Patients With Intracranial Pediatric Ependymoma.

Fatima Tensaouti, Anne Ducassou, Léonor Chaltiel, Stéphanie Bolle, Jean Louis Habrand, Claire Alapetite, Bernard Coche-Dequeant, Valérie Bernier, Line Claude, Christian Carrie and 11 more

Registry-linked trialOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05151718 (Ependymomics), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05151718 recruitingnot on this mapstarted 2021, after this paper: background citation

Ependymomics: Multiomic Approach to Radioresistance of Ependymomas in Children and Adolescents

TypeobservationalSponsorInstitut Claudius RegaudRan2021 to 2026Enrolled370ConditionsEpendymoma of Brain, Pediatric Solid Tumor
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 14 institutions in 1 country.

Fatima TensaoutiToNIC, Toulouse NeuroImaging Center, Universite de Toulouse, Inserm, Toulouse, France.
Anne DucassouDepartment of Radiation Oncology, Institut Claudius Regaud, Institut Universitaire du, Cancer de Toulouse-Oncopole, Toulouse, France.
Léonor ChaltielDepartment of Biostatistics, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
Stéphanie BolleDepartment of Radiotherapy Oncology, Institut Gustave Roussy, Villejuif, France.
Jean Louis HabrandDepartment of Radiation Oncology, Centre Francois Baclesse, Caen, France.
Claire AlapetiteDepartment of Radiation Oncology, Institut Curie, Paris, France.
Bernard Coche-DequeantDepartment of Radiation Oncology, Oscar Lambret Centre, Lille, France.
Valérie BernierDepartment of Radiation Oncology, Centre Alexis Vautrin, Vandœuvre-lès-Nancy, France.
Line ClaudeDepartment of Radiation Oncology, Centre Léon Bérard, Lyon, France.
Christian CarrieDepartment of Radiation Oncology, Centre Léon Bérard, Lyon, France.
Laetitia PadovaniDepartment of Radiation Oncology, CHU La Timone, Marseille, France.
Xavier MuraccioleDepartment of Radiation Oncology, CHU La Timone, Marseille, France.
Stéphane SupiotDepartment of Radiation Oncology, Institut de Cancerologie de l'Ouest, Nantes, France.
Aymeri HuchetDepartment of Radiation Oncology, Centre Hospitalier et Universitaire, Bordeaux, France.
Julie LeseurDepartment of Radiation Oncology, Centre Eugéne Marquis, Rennes, France.
Christine KerrDepartment of Radiation Oncology, Institut Regional du Cancer Montpellier, Val d'Aurelle, Montpellier, France.
Grégorie HangardDepartment of Engineering and Medical Physics, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
Albert LisbonaDepartment of Radiation Oncology, Institut de Cancerologie de l'Ouest, Nantes, France.
Farid GoudjilDepartment of Radiation Oncology, Institut Curie, Paris, France.
Régis FerrandDepartment of Engineering and Medical Physics, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
Anne LaprieToNIC, Toulouse NeuroImaging Center, Universite de Toulouse, Inserm, Toulouse, France.
Institut universitaire du cancer de Toulouse Oncopole · FRCentre Léon Bérard · FRHôpital de la Timone · FRInstitut Curie · FRInstitut de Cancérologie de l'Ouest · FRCentre Eugène Marquis · FRCentre François Baclesse · FRCentre Hospitalier Universitaire de Bordeaux · FRCentre Oscar Lambret · FRDélégation Centre-Est · FRInstitut Claudius Regaud · FRInstitut de Recherche en Cancérologie de Montpellier · FRInstitut Gustave Roussy · FRUniversité Fédérale de Toulouse Midi-Pyrénées · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

boostependymomaintracranialphoton therapyproton therapytreatment planning

Identifiers

PMID31293971
PMCPMC6598548
OpenAlexW2952768675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.